Fact-checked by Grok 2 weeks ago

Fructose malabsorption

Fructose malabsorption is a common digestive disorder in which the small intestine incompletely absorbs , a found in fruits, , and many processed foods, leading to its passage into the colon where it draws and is fermented by , causing osmotic and gas . This condition differs from , a rarer genetic , and is instead a functional often linked to the of intestinal transporters like GLUT5. Symptoms typically include , , , , and sometimes , which can mimic () and affect quality of life, particularly after consuming fructose-rich foods such as apples, pears, or . The of fructose malabsorption varies by and testing but is estimated to up to 30-40% of healthy individuals when challenged with higher doses (e.g., 25-50 grams of ), with higher rates in children under 3 years (around 70%) that decrease with age. It is particularly common among people with IBS, where approximately one-third may have fructose malabsorption contributing to their symptoms. Causes are not fully elucidated but may involve reduced expression or function of fructose transporters, intestinal mucosal damage, rapid transit time, or excessive dietary intake overwhelming capacity, without consistent genetic mutations identified. primarily relies on the , where a rise in breath or levels after ingesting a (typically 25 grams for adults) indicates , though results can vary due to factors like recent use or . Management focuses on dietary modifications, such as a low (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet that restricts high-fructose foods like certain fruits, sweeteners (e.g., , ), and processed items, often leading to symptom improvement in 70% of cases under professional guidance. Co-ingesting glucose with can enhance absorption and alleviate symptoms, while emerging treatments include enzymes like to convert to glucose in the gut. Consultation with a registered is recommended to avoid nutritional deficiencies, as unrestricted avoidance can limit and nutrient intake from fruits and .

Introduction and Background

Definition

Fructose malabsorption is a digestive disorder characterized by the impaired absorption of in the , primarily due to reduced capacity or expression of the transporter protein, which facilitates fructose uptake across the intestinal epithelium. This inefficiency results in unabsorbed accumulating in the intestinal , exerting osmotic effects that draw into the gut and promoting bacterial fermentation in the colon. The condition is a common, non-genetic estimated to affect 30% to 40% of healthy individuals in populations when challenged with a 25 g dose of , with gastrointestinal symptoms that are typically reversible through dietary restriction of fructose intake. In contrast, (HFI) is a rare genetic condition caused by mutations in the ALDOB gene, leading to a deficiency in enzyme and severe, potentially life-threatening metabolic disturbances upon fructose exposure. Historically, malabsorption was termed "dietary fructose intolerance" to describe its link to dietary triggers, but the standardized nomenclature of is now used to avoid confusion with the distinct of HFI.

Fructose malabsorption is detected in an estimated 40% of individuals in populations upon with a 25 g fructose load, where diets high in processed foods contribute to its commonality. In , the prevalence of malabsorption of simple carbohydrates, including fructose, ranges from 20% to 30% among the general population. Rates are notably higher among those with (IBS), reaching 36% to 75% in patients with functional bowel disorders. In contrast, prevalence appears lower in non- populations with diets low in processed fructose, though specific data remain limited due to dietary differences. Key risk factors include high-fructose diets, which exceed absorption thresholds and promote . Co-existing conditions such as celiac disease and are associated with increased risk, as they impair intestinal function. Regarding age, is more prevalent in infants and young children, with rates approximately 88% in those under 1 year, 67% in 1- to 5-year-olds, 40% in 6- to 10-year-olds, and 27% in 10- to 15-year-olds, and absorption capacity improving progressively into adulthood. There is no strong inherent bias, though reports are more frequent in females due to the higher prevalence of IBS in this group. Incidence trends show a rise since the , coinciding with the widespread introduction of in processed foods, which increased average fructose intake beyond safe absorption levels around 1980. Recent studies through 2025 continue to document elevated rates in Western and European cohorts, underscoring the impact of dietary shifts.

Pathophysiology

Normal Fructose Absorption

is a found in various dietary sources, including fruits, , and as a component released from the breakdown of by the sucrase-isomaltase in the . In normal physiology, is primarily absorbed in the , the middle section of the , where it enters enterocytes through facilitative transport mechanisms. The uptake of fructose occurs via the glucose transporter 5 (GLUT5), a fructose-specific transporter located on the apical membrane of enterocytes, which facilitates its movement from the intestinal lumen into the cell without requiring sodium. Once inside the enterocyte, fructose exits across the basolateral membrane into the bloodstream primarily through GLUT2, another facilitative transporter that can handle multiple sugars including fructose, glucose, and galactose. This process ensures efficient delivery of absorbed fructose to the portal vein for hepatic metabolism. Absorption efficiency is notably enhanced when fructose is co-ingested with glucose, particularly at a fructose-to-glucose ratio of 1:1 or less, as glucose stimulates the insertion of into the apical membrane and may promote transient GLUT2 recruitment to the apical side. In healthy adults, the intestinal capacity for fructose absorption typically ranges from 25 to 50 grams per day, though this can vary individually based on transporter expression and dietary context. Under normal conditions, with intakes within this capacity, unmetabolized fructose reaching the colon is minimal, limiting bacterial .

Mechanisms of Malabsorption

Fructose malabsorption primarily arises from impaired function or reduced expression of the 5 (GLUT5), encoded by the SLC2A5 gene, which is the main apical membrane transporter responsible for uptake in the . Low GLUT5 expression limits the intestine's capacity to absorb , particularly when intake exceeds the transporter's threshold, such as doses above 25-50 grams, leading to incomplete absorption even in healthy individuals. This overload can occur with high-fructose diets common in processed foods, overwhelming the facilitative transport system without involving enzymatic deficiencies. Contributing factors include genetic variations in SLC2A5, though these are rare and typically linked to isolated cases rather than widespread acquired malabsorption. Gut inflammation, as seen in conditions like Helicobacter pylori infection or colitis, downregulates GLUT5 expression through cytokine-mediated effects, further impairing absorption. In children, age-related immaturity of GLUT5 plays a significant role; expression and regulatory capacity develop post-weaning, resulting in higher malabsorption rates—up to 88% in infants under 1 year, decreasing to 27% by ages 10-15. Unabsorbed fructose exerts an osmotic effect in the intestinal , drawing into the bowel and promoting through increased luminal osmolarity. Reaching the colon, it undergoes rapid by , primarily producing , , , and , which contribute to gas accumulation and . Unlike , which stems from enzyme deficiency in the liver leading to toxic buildup, fructose malabsorption involves no hepatic enzymatic defects and remains confined to intestinal issues.

Clinical Features

Symptoms

Fructose malabsorption primarily manifests as gastrointestinal symptoms triggered by the ingestion of unabsorbed , which draws water into the intestinal osmotically and undergoes bacterial in the colon, producing gases and . Common symptoms include abdominal , pain or discomfort, excessive , (or occasionally ), and , often accompanied by and intestinal distension. These symptoms typically onset between 1.5 and 3 hours after consumption, correlating with the peak in breath levels during diagnostic testing, and generally resolve within 24 to 48 hours once the unabsorbed is cleared from the gut. The severity is dose-dependent, with most healthy individuals absorbing up to 25 grams of without issue, but doses exceeding this threshold—such as 50 grams—provoking and symptoms in 70-80% of people, including those without underlying conditions. In patients with (IBS), fructose malabsorption is more prevalent (36-75%) and symptoms are often more pronounced, with bloating, , and altered bowel habits exacerbating the disorder's overall presentation. Chronic or repeated exposure to poorly tolerated fructose levels may lead to , potentially stemming from associated nutrient and central nervous system effects reported in over 50% of affected individuals. Unlike , fructose malabsorption does not typically cause systemic symptoms such as .

Complications and Associated Conditions

Unmanaged fructose malabsorption can lead to nutritional complications primarily through chronic osmotic , which accelerates the loss of , electrolytes, and essential nutrients. This may result in deficiencies of various vitamins and minerals due to impaired and increased fecal excretion. In severe or prolonged cases, individuals may experience significant and , manifesting as , muscle wasting, and reduced growth in children. Fructose malabsorption shows a strong overlap with (IBS), with prevalence rates in IBS patients ranging from 36% to 75%, compared to 0-50% in healthy controls. This association arises from shared mechanisms of fermentation in the gut, exacerbating IBS symptoms when intake is not restricted. Emerging research indicates links between fructose malabsorption and mood disorders, such as anxiety and , mediated by impaired absorption. Reduced availability limits serotonin synthesis, a key , potentially contributing to depressive symptoms; a 2001 study showed lower plasma levels and higher scores in affected individuals. A 2025 preclinical study in mice suggested that fructose malabsorption induces and increases anxiety-like behaviors. Other risks include gut , where unabsorbed promotes shifts in composition, increasing pro-inflammatory like Proteobacteria while decreasing beneficial Bacteroidetes. This heightens susceptibility to (SIBO), particularly in IBS patients with overlapping conditions. If is ignored, there is an association with broader carbohydrate intolerances, such as combined and malabsorption.

Diagnosis

Diagnostic Tests

The primary diagnostic method for fructose malabsorption is the hydrogen-methane breath test, considered the gold standard due to its non-invasive nature and ability to detect unabsorbed fructose through bacterial products in the breath. Patients fast overnight, brush their teeth, and rinse with antiseptic mouthwash before providing baseline end-expiratory breath samples for and measurement. They then ingest a 25 g fructose solution in , followed by breath sampling every 15-30 minutes for 2-4 hours. A positive test is indicated by a rise in exceeding 20 parts per million () above baseline or an increase in , reflecting colonic of malabsorbed ; some protocols use a higher 50 g dose for greater sensitivity in symptomatic cases. An elimination diet trial serves as a practical confirmatory approach, particularly when breath testing is inconclusive or unavailable. Under guidance from a registered , patients restrict intake to less than 10-15 g per day for 4-6 weeks, avoiding high- foods like fruits, , and certain sweeteners while monitoring symptom resolution through a food and symptom . If symptoms improve, controlled reintroduction of -containing foods (starting at 5-10 g doses) helps establish individual tolerance thresholds; persistent symptom relief during restriction supports the . Supporting tests include stool analysis for reducing sugars, which detects unabsorbed carbohydrates like in fecal samples via the Clinitest reaction (a color change indicating reducing substances). This test is most useful in pediatric cases with , requiring a fresh sample collected after recent fructose ingestion, but it lacks specificity as it also detects other sugars such as glucose or . for (HFI), involving sequencing of the ALDOB gene for biallelic pathogenic variants, is not routine for fructose malabsorption but is recommended only if HFI is suspected due to severe symptoms or metabolic disturbances like .

Differential Diagnosis

Fructose malabsorption (FM) must be differentiated from (HFI), a rare caused by deficiency of the , which leads to accumulation of fructose-1-phosphate in the liver and kidneys, resulting in severe symptoms such as , , , and potentially upon ingestion, typically presenting in infancy or . In contrast, FM arises from impaired transport of across the intestinal mucosa via the transporter, causing primarily gastrointestinal symptoms like and without systemic metabolic disturbances. FM shares significant symptom overlap with (IBS), including , bloating, flatulence, and altered bowel habits, but IBS is diagnosed based on the Rome IV criteria emphasizing recurrent associated with or changes in stool frequency/form, without requiring confirmation. FM is confirmed via breath testing after ingestion, and it affects approximately one-third of IBS patients, often contributing to their symptoms. Other conditions mimicking FM include , which involves deficiency leading to undigested fermentation in the colon, producing similar osmotic and gas; it is distinguished by a dedicated . Celiac disease, an autoimmune enteropathy triggered by , can cause secondary FM due to villous atrophy impairing nutrient absorption, but requires duodenal biopsy and serologic testing (e.g., anti-tissue antibodies) for diagnosis, unlike the breath test for primary FM. (SIBO) overlaps in symptoms and breath test results due to bacterial fermentation, but is identified by response to antibiotics and often distinguished through breath testing patterns. Fructan sensitivity, involving malabsorption of (oligosaccharides found in and onions), produces comparable gastrointestinal effects but is linked to specific foods rather than free , with no standardized breath test available, complicating differentiation from pure FM. Diagnostic challenges arise from overlaps within FODMAP sensitivities, as FM frequently coexists with other carbohydrate s; a 2024 study of 186 IBS patients found 38.2% had FM, 48.9% had malabsorption, and 22.6% had both, with a significant association ( 1.951).

Management and Treatment

Dietary Management

The primary dietary strategy for managing fructose malabsorption involves restricting intake of fermentable carbohydrates, particularly through the , which serves as the first-line approach. This diet limits fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs), including excess , for an initial elimination phase of 4-6 weeks, followed by a structured reintroduction to identify individual tolerances. Clinical trials have demonstrated its effectiveness, with 70% of patients with (IBS)—a condition often overlapping with fructose malabsorption—reporting significant symptom improvement during the elimination phase. A key component of this strategy is adhering to the fructose-to-glucose ratio in foods, as glucose facilitates in the via co-transport mechanisms. Foods where fructose exceeds glucose content should be limited or avoided, such as certain fruits like apples and pears, while those with a balanced or glucose-dominant ratio are better tolerated. Individual tolerance typically ranges from 10-15 grams of fructose per day, depending on factors like meal composition and overall gut health. Practical implementation emphasizes portion control to maintain symptom relief without overly restrictive eating patterns. For instance, limiting intake to less than one small serving per meal helps prevent overload, while incorporating glucose-rich foods alongside moderate sources can enhance . Long-term adherence, supported by monitoring through food diaries to track intake and symptoms, achieves symptom reduction in 50-70% of patients, with studies showing sustained benefits in 57% of patients after 6-18 months of adherence.

Pharmacological and Supplemental Interventions

Pharmacological and supplemental interventions for primarily focus on adjunctive therapies to enhance fructose digestion, modulate , or alleviate associated gastrointestinal symptoms, often used alongside dietary modifications. These approaches do not directly cure the but can reduce symptom severity in affected individuals. supplements containing represent a targeted option to improve fructose absorption by enzymatically converting unabsorbed fructose to glucose in the intestinal , thereby minimizing osmotic effects and bacterial . Commercial products such as Fructaid, Fructase, and Fructosin deliver this enzyme, typically dosed at 1-2 tablets taken immediately before consuming fructose-containing meals to optimize . A double-blind, placebo-controlled trial demonstrated that oral significantly reduced breath hydrogen excretion—a marker of fructose malabsorption—and improved symptoms including and in participants with confirmed fructose intolerance. This intervention is generally well-tolerated, though long-term safety data remain limited, and further clinical validation is recommended for broader application. Probiotics, particularly strains of Bifidobacterium such as B. infantis or multi-strain formulations, may help by promoting a balanced , which can decrease excessive of malabsorbed and mitigate and pain. In patients with (IBS) exhibiting fructose malabsorption—a common overlap—probiotic supplementation has been shown to restore Bifidobacterium populations depleted by low-FODMAP diets and correlate with symptom relief, including reduced abdominal discomfort. A 2025 review of intolerance management highlighted ' role in alleviating gas production from malabsorbed sugars like , with from randomized controlled trials supporting their use for up to 8 weeks in IBS contexts. These benefits are strain-specific and most pronounced in constipation-predominant IBS subtypes associated with fructose sensitivity. Symptomatic relief from and cramping can be achieved with such as or , which relax intestinal and are indicated for IBS-like symptoms triggered by malabsorption. Clinical studies in IBS patients, where intolerance often contributes to visceral , have reported that hyoscine (a related ) outperforms in reducing pain over 4-12 weeks of treatment. These agents are typically prescribed short-term to avoid side effects like dry mouth. In cases where small intestinal bacterial overgrowth (SIBO) coexists with fructose malabsorption—exacerbating fermentation and symptoms—antibiotics like are employed to target overgrowth without systemic absorption. has demonstrated superior efficacy over in resolving SIBO-related and in IBS patients, with a 2-week course often sufficient for symptom improvement when fructose malabsorption is a contributing factor. Routine use is reserved for confirmed SIBO via breath testing, as not all fructose malabsorption cases involve bacterial overgrowth.

Food Considerations

Foods to Avoid

Individuals with fructose malabsorption should avoid foods where fructose content exceeds glucose, as this ratio greater than 1:1 impairs absorption in the via the transporter, leading to gastrointestinal symptoms. Common high-fructose fruits include apples, pears, mangoes, and , which often contain more than 50% of their content as relative to glucose. For instance, apples have a fructose-to-glucose ratio of approximately 3:1, making even moderate portions problematic. Sweeteners such as (HFCS), nectar, and are primary sources to eliminate, as HFCS typically contains 55% and agave up to 90%, both exceeding balanced ratios. Processed foods incorporating these include sodas, candies, and fruit juices, particularly those from apple or concentrates, which can deliver rapid fructose loads. Baked goods, cereals, and sauces often hide HFCS or added , contributing to unintended intake. Dried fruits and jams represent concentrated forms of excess , amplifying risks even in small servings due to increasing . Certain like onions and , while primarily containing fructans (fructose polymers), can exacerbate symptoms as fructans are malabsorbed and fermented by gut bacteria in the colon, drawing water and producing gas, though pure -focused avoidance prioritizes fruits and sweeteners. When reading labels, scrutinize for "," "HFCS," "fruit juice concentrate," or hidden sources in condiments and ready-to-eat meals to prevent cumulative exposure. Recent guidelines emphasize keeping total daily intake below 25 grams to minimize symptoms, as higher amounts often trigger even in tolerant individuals, with personalized thresholds potentially lower based on breath testing.

Foods to Include

Individuals with fructose malabsorption can incorporate a variety of low-fructose foods into their diet to maintain nutritional balance while minimizing symptoms, focusing on items where content is low or balanced with equal or greater amounts of glucose. Suitable fruits include bananas, strawberries, blueberries (in small portions), such as , , , and , as these have levels at or below glucose, aiding absorption. Vegetables like carrots, potatoes, , green beans, , , , and are generally low in and can be consumed freely in moderate portions. Grains such as , oats, , and corn-based products (without added ) provide essential carbohydrates without significant fructose content. Proteins including meats, , , eggs, and firm are naturally fructose-free and form a staple of the . Dairy products like hard cheeses and lactose-free milk can be included if is not present. Table sugar (), which consists of equal parts glucose and , is well-tolerated in moderation as the glucose facilitates absorption. Small portions of grapes or additional blueberries may also be suitable for some, depending on individual tolerance. To ensure nutritional adequacy, emphasize dietary variety across these categories, such as limiting bananas to one per day and combining with proteins or grains, drawing from low guidelines to avoid deficiencies in , vitamins, and minerals.

Research and Future Directions

Current Research Findings

Recent studies have elucidated the role of in inducing gut , with a 2025 preprint demonstrating that FM triggers shifts in composition in both cohorts and models, leading to increased anxiety-like behaviors through microglia-dependent and altered gut-brain axis signaling. While models, such as Glut5-knockout mice, confirm alterations, the specific compositional changes remain inconclusive, though they are linked to modulated serotonin pathways contributing to dysregulation. In patients with (IBS), a 2024 study reported a significant association between FM and malabsorption, with 38.2% of IBS patients exhibiting FM and 48.9% showing malabsorption, including 22.6% co-occurrence; patients with one malabsorption had nearly twice the odds (OR 1.951) of the other, prompting recommendations for combined breath testing to improve diagnostic accuracy. FM has been implicated in mood disorders through reduced absorption, as a 2024 analysis indicated that inhibited tryptophan resorptions in FM patients lead to decreased serotonin synthesis, exacerbating internalizing psychological symptoms in children and adolescents. Additionally, FM prevalence appears elevated in pediatric populations with , with functional abdominal pain disorders—affecting up to 40% of children—often linked to FM and other food intolerances. No major genetic breakthroughs have emerged in 2024-2025 research on , though associations with variants in fructose transporter genes like continue to be explored without definitive causal links. Rising dietary intake, particularly from formulations exceeding safe absorption thresholds, has been highlighted as a trend driving increased FM incidence and related gut health disruptions.

Emerging Therapies

Recent studies have highlighted microbiota-targeted approaches as promising for managing fructose malabsorption by restoring gut balance and enhancing fructose clearance. A 2025 preclinical investigation showed that prebiotic supplementation with adapts the gut to metabolize dietary in the , reducing its delivery to the liver and colon while increasing short-chain production by beneficial such as Bacteroides acidifaciens, thereby alleviating associated metabolic issues like hepatic steatosis. In a 2025 case report, fecal microbiota transplantation successfully restored tolerance to multiple foods in a pediatric with severe multi-food intolerance, including fructose-related symptoms, by normalizing stool consistency, reducing rashes, and improving nutritional status through reconstitution. Enzyme-based therapies are advancing with optimized formulations of , which enzymatically converts unabsorbed to absorbable glucose in the gut, demonstrating reduced breath hydrogen excretion and improved and in clinical settings. A 2025 European consensus on endorses as a safe, over-the-counter supplement for symptom relief in fructose malabsorption, noting its non-allergenic profile and efficacy in double-blind trials. Emerging prospects also include AI-driven personalized nutrition tools for precise fructose tracking and dietary optimization. Applications like Foodient use image recognition to scan foods and assess safety for intolerances, including , enabling users to log intake and avoid triggers effectively. In 2024 IBS research, targeted low-FODMAP therapies emphasizing restriction—often co-occurring with malabsorption—proved as effective as broader elimination in reducing symptoms, offering a more sustainable combined approach.

References

  1. [1]
    Fructose malabsorption - PMC - NIH
    Feb 16, 2016 · Incomplete intestinal absorption of fructose might lead to abdominal complaints such as pain, flatulence and diarrhoea.Missing: treatment | Show results with:treatment
  2. [2]
    Fructose malabsorption: causes, diagnosis and treatment
    Apr 5, 2021 · Current treatments of FM include dietary intervention, such as low fermentable oligo-, di-, monosaccharides and polyols diets and enzymatic treatments.
  3. [3]
    Fructose intolerance: Which foods to avoid? - Mayo Clinic
    When the digestive system doesn't absorb fructose properly, it can cause stomach pain, bloating, diarrhea and gas. This is known as fructose intolerance.
  4. [4]
    Fructose malabsorption: causes, diagnosis and treatment - PubMed
    Feb 28, 2022 · Current treatments of FM include dietary intervention, such as low fermentable oligo-, di-, monosaccharides and polyols diets and enzymatic treatments.Missing: definition | Show results with:definition
  5. [5]
    Fructose Malabsorption and Intolerance - NIH
    The inability to properly utilize fructose manifests in one of two forms: 1) a genetic aberration termed “hereditary fructose intolerance,” resulting from a ...
  6. [6]
    Hereditary Fructose Intolerance - GeneReviews® - NCBI Bookshelf
    Dec 17, 2015 · Fructose malabsorption (or "dietary fructose intolerance"), in which fructose transporters in the small intestine are dysfunctional, is ...
  7. [7]
    Hereditary fructose intolerance: MedlinePlus Genetics
    Jun 1, 2011 · In people with fructose malabsorption, the cells of the intestine cannot absorb fructose normally, leading to bloating, diarrhea or constipation ...
  8. [8]
    Hereditary fructose intolerance: MedlinePlus Genetics
    Jun 1, 2011 · In people with fructose malabsorption, the cells of the intestine cannot absorb fructose normally, leading to bloating, diarrhea or constipation ...
  9. [9]
    The Malabsorption of Commonly Occurring Mono and Disaccharides
    The malabsorption of simple carbohydrates is the most common type of non-immune-mediated food intolerance, affecting 20% to 30% of the European population.
  10. [10]
    Prevalence of Fructose Malabsorption in Patients With Irritable ...
    One study showed that the prevalence of 25-g fructose malabsorption is higher in patients with functional bowel disorders (36–75%) than healthy controls (0–50%) ...
  11. [11]
    A Prospective Multicenter Study on the Prevalence of Fructose ...
    Jun 9, 2020 · The number of patients diagnosed with fructose malabsorption – 35/44 (79.6%) in patients with active IBD, 59/80 (73.8%) inactive IBD, and 66/81 ...
  12. [12]
    40 years of adding more fructose to high fructose corn syrup than is ...
    Feb 2, 2024 · Intake exceeded dosages that trigger malabsorption (~ 5 g) around ~ 1980. By the early 1980's, tripled apple juice intake had added ~ 0.5 g to ...
  13. [13]
    Celiac Disease and Fructose Intolerance | BeyondCeliac.org
    Dietary fructose intolerance (DFI) is fairly common and not life-threatening. Also known as fructose malabsorption, this condition is estimated to affect ...
  14. [14]
    How To Tell If You Have Fructose Intolerance - Verywell Health
    Fructose intolerance appears to be affected both by the amount of fructose in your diet and digestive diseases like: Inflammatory bowel diseases, like Crohn's ...Missing: age | Show results with:age
  15. [15]
    Effect of Age on Fructose Malabsorption in Children Presenting With ...
    May 1, 2011 · The majority of infants with gastrointestinal symptoms exhibited fructose malabsorption, but the capacity to absorb fructose increased with patient age up to ...Missing: prevalence | Show results with:prevalence
  16. [16]
    Symptomatic fructose malabsorption in irritable bowel syndrome: A ...
    Apr 1, 2014 · After a 25 g fructose load, symptomatic fructose malabsorption and intolerance without malabsorption were detected in 22% and 28% of IBS ...
  17. [17]
    [PDF] European Consensus on Malabsorption—UEG & SIGE, LGA, SPG ...
    Feb 14, 2025 · Intolerance to carbohydrates is relatively common in childhood and adolescence and the prevalence has increased during the last few decades due ...
  18. [18]
    Biochemistry, Fructose Metabolism - StatPearls - NCBI Bookshelf - NIH
    Oct 17, 2022 · Fructose is an abundant monosaccharide in the human diet that the body needs to metabolize. It is present in honey, fruits, vegetables, and high-fructose corn ...
  19. [19]
    Mechanisms Of Fructose Absorption - PMC - NIH
    Nov 5, 2015 · It is widely accepted that fructose is absorbed via glucose transporters (GLUT) in the intestine, mainly GLUT-2 and GLUT-5.
  20. [20]
    Absorption capacity of fructose in healthy adults. Comparison ... - NIH
    It is concluded that in the healthy state the absorption capacity of fructose given alone ranges from less than 5 g to more than 50 g.Missing: ratio | Show results with:ratio
  21. [21]
    Intestinal fructose transport and malabsorption in humans
    Feb 1, 2011 · Patients who exhibit fructose malabsorption can present with gastrointestinal symptoms that include chronic diarrhea and abdominal pain.<|control11|><|separator|>
  22. [22]
    The role of fructose transporters in diseases linked to excessive ...
    Nov 12, 2012 · Low or modest expression of the fructose transporter GLUT5 may cause intestinal fructose malabsorption in humans. A, fructose malabsorption ...
  23. [23]
    Regulation of the fructose transporter GLUT5 in health and disease
    Isolated fructose malabsorption is rare and is not linked to protein-altering mutations in GLUT5, and the inheritance pattern is unknown (153). As a consequence ...
  24. [24]
    Dietary fructose intolerance, fructan intolerance and FODMAPs - NIH
    One study has estimated that up to one third of patients with suspected IBS had fructose malabsorption and dietary fructose intolerance (DFI) [8].
  25. [25]
    Is Fructose Malabsorption a Cause of Irritable Bowel Syndrome? - NIH
    Fructose malabsorption leads to osmotic diarrhea as well as gas and bloating due to fermentation in the colon. A low-fructose diet has been found to improve IBS ...
  26. [26]
    The Ability of the Normal Human Small Intestine to Absorb Fructose
    Healthy subjects have the capacity to absorb up to 25g fructose whereas many exhibit malabsorption and intolerance with 50g fructose.Missing: ratio | Show results with:ratio
  27. [27]
    Fructose and lactose intolerance and malabsorption testing
    The breath tests were performed in randomised, patient-blinded sequence on two separate occasions at least 4 days apart. ... Fructose malabsorption and symptoms ...
  28. [28]
    Malabsorption (Syndrome): Symptoms, Causes & Treatment
    Malabsorption syndrome is a disorder in your digestive system. It means you have trouble absorbing nutrients from your food.
  29. [29]
    Malabsorption Syndromes - StatPearls - NCBI Bookshelf
    Jul 7, 2025 · Malabsorption syndromes typically are not life-threatening. · Food intolerances, eg, lactose intolerance and malabsorption, rarely cause serious ...
  30. [30]
    The association between fodmaps intake and psychological ... - Nature
    Jul 8, 2025 · However, fructose malabsorption has been associated with reduced plasma levels of L-tryptophan, a precursor to serotonin. It has been proposed ...
  31. [31]
    Fructose Malabsorption, Gut Microbiota and Clinical Consequences
    The prevalence and severity of fructose malabsorption in humans thus appears to decrease with age [26]. In adults, fructose malabsorption, as evaluated by ...
  32. [32]
    Prevalence of Fructose Malabsorption in Patients With Irritable ... - NIH
    Fructose malabsorption (FM) mimics symptoms of irritable bowel syndrome (IBS), and its prevalence has increased. Diagnosing FM in IBS is challenging because ...<|control11|><|separator|>
  33. [33]
    Fructose malabsorption and fructan malabsorption are associated in ...
    Apr 24, 2024 · Our results reveal a clinically significant association between fructose malabsorption and fructan malabsorption in patients with IBS.<|separator|>
  34. [34]
    The Predictive Value of the Hydrogen Breath Test in the Diagnosis ...
    Sep 4, 2018 · Primary fructose malabsorption is commonly diagnosed by a hydrogen fructose (H2) breath test [7]. The H2 breath test is the standard test in ...
  35. [35]
    How to Interpret Hydrogen Breath Tests - PMC - NIH
    For this reason, the cut-off value of hydrogen to estimate oro-cecal transit time, lactose and fructose malabsorption is 20 ppm above basal; in contrast, the ...Missing: threshold | Show results with:threshold
  36. [36]
  37. [37]
    Stool Reducing Sugars | myadlm.org
    Dec 12, 2023 · Although sucrose is not a reducing sugar, it is often metabolized by bacteria to glucose and fructose. The reaction is not specific for sugars.What does the test tell me? · Is the test result diagnostic...
  38. [38]
    Poorly Responsive Celiac Disease
    People with celiac disease may have lactose or fructose intolerance, both of which can be diagnosed by a hydrogen breath test. Some research has shown that ...
  39. [39]
    Efficacy of the low FODMAP diet for treating irritable bowel syndrome
    They found that 70% of IBS subjects (across all four subtypes of IBS) felt better on the low FOD-MAP diet, whereby the greatest symptom control was achieved and ...
  40. [40]
    [PDF] Low Fructose Diet
    A low fructose diet limits fructose, found in fruits, vegetables, honey, and high fructose corn syrup, due to intolerance causing symptoms like bloating. Limit ...
  41. [41]
    [PDF] Long-term impact of the low-FODMAP diet on gastrointestinal ...
    After a median of 16 months following FODMAP education, 86% of patients with IBS and inflammatory bowel disease reported a partial (54%) or full (32%) symptom ...
  42. [42]
    Excess free fructose, apple juice, high fructose corn syrup and ...
    Jun 23, 2020 · Excess-free-fructose is fructose which occurs when the fructose-to-glucose ratio exceeds 1:1, as in HFCS and apple juice. Most natural foods ...
  43. [43]
    [PDF] Fructose Table - Nepean Naturopathic Centre
    Unfavorable foods (i.e. more fructose than glucose). •. Fruit - Apple, pear, guava, honeydew melon, nashi fruit, pawpaw/papaya, quince, star fruit, watermelon.
  44. [44]
    Fructose intolerance: Symptoms, treatment, and foods to avoid
    Causes and risk factors. The causes and risk factors for the three types of fructose intolerance are as follows. Fructose malabsorption. Fructose malabsorption ...Missing: age | Show results with:age
  45. [45]
  46. [46]
    Fructose intolerance - AGA GI Patient Center
    Examples of some common high fructose foods/ingredients to stay away from: · Agave nectar · Fructose or crystalline fructose · Honey · Karo light corn syrup · Fruit ...
  47. [47]
    The facts about glucose and fructose - Monash Fodmap
    Apr 3, 2016 · Fructose is better absorbed with glucose, but many have poor absorption of fructose alone. Foods with higher fructose than glucose are avoided ...<|separator|>
  48. [48]
    High and low FODMAP foods
    High FODMAP foods include apples, pears, garlic, and onion. Low FODMAP alternatives include eggplant, bok choy, and cucumber.Frequently asked questions · Low FODMAP diet resources · Traffic light system
  49. [49]
  50. [50]
    Internalizing psychological symptoms in children and adolescents ...
    Jul 11, 2024 · Due to an inhibited tryptophan resorption, patients with fructose malabsorption are expected to experience decreased serotonin synthesis.
  51. [51]
    (PDF) Functional Abdominal Pain Disorders in Children May Be ...
    Apr 15, 2025 · ... fructose malabsorption; HIT, histamine intolerance. 5. Discussion. FAPDs are very common, with an estimated prevalence ranging up to 40% in ...
  52. [52]
    40 years of adding more fructose to high fructose corn syrup than is ...
    Feb 2, 2024 · 40 years of adding more fructose to high fructose corn syrup than is safe, through the lens of malabsorption and altered gut health–gateways to chronic disease.
  53. [53]
    Dietary fibre-adapted gut microbiome clears dietary fructose ... - Nature
    Sep 15, 2025 · Together, these data suggest that inulin supplementation enhances fructose catabolism by the microbiome of the small intestine, without ...Missing: malabsorption | Show results with:malabsorption
  54. [54]
  55. [55]
    European Consensus on Malabsorption—UEG & SIGE, LGA, SPG ...
    Mar 15, 2025 · Overall, there were 23 cases of intestinal malabsorption, with the highest incidence occurring with ARBs. According to a very recent systematic ...